Why TransEnterix Inc. [TRXC] Stock Still Has Countless Sunny Days Ahead

TransEnterix Inc. [TRXC] has traded in a range of $0.28 to $2.69 in the last 1 year. As of this writing, the stock is at $0.52, up 8.76%. To check whether the stock’s short-term amount has a thrust, its good to check stock’s recent movement. Over the last week, TRXC shares are 11.79% up with the monthly amount drift of 31.57% and seems well in a long time frame.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .


On 5, November 2020, TransEnterix, Inc. Reports Operating and Financial Results for the Third Quarter 2020. According to news published on Yahoo Finance, TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced its operating and financial results for the third quarter of 2020.

Analyst Birdseye View:

The most recent analyst activity for TransEnterix Inc. [AMEX:TRXC] stock was on May 22, 2019, when it was Initiated with a Neutral rating from Piper Jaffray, which also raised its 12-month price target on the stock to $1.60. Before that, on August 08, 2019, RBC Capital Mkts Recapitulated a Sector perform rating and elevated its amount target to $1. On May 14, 2019, BTIG Research Upgrade a Buy rating and boosted its price target on this stock to $3. On November 09, 2018, Ladenburg Thalmann Upgrade a Buy rating. On May 29, 2018, Ladenburg Thalmann Downgrade a Neutral rating. On October 30, 2017, Stifel Reiterated a Buy rating and boosted its amount target on this stock to $4. On January 19, 2017, Raymond James Downgrade a Mkt perform rating. Lake Street elevated its amount target by recapitulating a higher weight for this stock.

In the past 52 weeks of trading, this stock has oscillated between a low of $0.28 and a peak of $2.69. Right now, according to Wall Street analyst the average 12-month amount target is $1.45. At the most recent market close, shares of TransEnterix Inc. [AMEX:TRXC] were valued at $0.52.


TransEnterix Inc. [AMEX:TRXC] most recently reported quarterly sales of 814.0 million, which represented growth of -60.00%. This publicly-traded organization’s revenue is $52,337 per employee, while its income is -$946,018 per employee. Continuing to look at profitability, this corporation’s Return on Assets, Equity, Whole Principal & invested Principal is sitting at -95.03, -137.65, -71.81 and -121.23 respectively.

If looking now at the Principal structure of this organization, it shows its whole liability to the whole Principal at 4.33 and the whole liability to whole assets at 3.12. It shows enduring liability to the whole principal at 2.41 and enduring liability to assets at 0.02 while looking for an extended time period.

Readers are usually of view to make a close observation to the indicators that support and make resistance before moving to any particular stock. As of now, the company’s stock is sitting at 0.4641 points at 1st support level, the second support level is making up to 0.4530. But as of 1st resistance point, this stock is sitting at 0.4881 and at 0.5010 for 2nd resistance point.

TransEnterix Inc. [TRXC] reported its earnings at -$0.12 per share in the fiscal quarter closing of 9/29/2020. The Analysts for Wall Street were expecting to report its earnings at -$0.23/share signifying the difference of 0.11 and 47.80% surprise value. Comparing the previous quarter ending of 6/29/2020, the stated earnings were -$0.21 calling estimates for -$0.38/share with the difference of 0.17 depicting the surprise of 44.70%.

Important Ratio’s To Watch

Meanwhile, turning our focus to liquidity, the Current Ratio for TransEnterix Inc. [AMEX:TRXC] is 3.20. Likewise, the Quick ratio is also the same, showing Cash ratio at 0.74. Now if looking for a valuation of this stock’s amount to sales ratio it’s 3.06 and it’s amount to book ratio is 0.55.

Insider Stories

The most recent insider trade was by Biffi Andrea, Director, and it was the purchase of 0.15 million shares on Feb 24. Starling William N JR, the Director, completed a sale of 9602.0 shares on Dec 19.